Orange Book product · Brand (NDA)
TUZISTRA XR
CHLORPHENIRAMINE POLISTIREX; CODEINE POLISTIREX
At a glance
Apr 30, 2015
Approved
Brand (NDA)
Application
Not listed
TE code
2
Listed patents
Key dates
Approval
FDA approval date of this drug product.
Apr 30, 2015
11 yr 4 mo ago
Today
Patent 8790700 expires
Listed drug product patent expiration.
Mar 15, 2027
in 9 mo
Patent 8062667 expires
Listed drug product patent expiration.
Mar 29, 2029
in 2 yr 10 mo
Pharmaceutical detail
Active ingredient
CHLORPHENIRAMINE POLISTIREX; CODEINE POLISTIREX
Strength
EQ 2.8MG BASE/5ML;EQ 14.7MG BASE/5ML
Dosage form
SUSPENSION, EXTENDED RELEASE
Route
ORAL
TE code
Not listed
Application
NDA 207768
Product number
001
Marketing status
DISCN
Reference listed drug (RLD)
Yes
Reference standard (RS)
No
Active-ingredient family
View full familyThis is a reference-listed drug (RLD) — the basis for generic (ANDA) applications. Other products sharing this ingredient are listed below.
Listed patents (2)
| Patent | Expires | In | Type |
|---|---|---|---|
| 8790700 | Mar 15, 2027 | in 9 mo | Product |
| 8062667 | Mar 29, 2029 | in 2 yr 10 mo | Product |

